"Das Institut für Pathologie versteht sich als Servicepartner der klinisch tätigen Disziplinen. Es leistet durch Diagnostik, Lehre und Forschungsarbeit darüber hinaus einen eigenständigen Beitrag zur Patientenversorgung und versorgt auch außerhalb der UMG die kooperierenden Lehrkrankenhäuser in der Region Göttingen und Südniedersachsen. In den vergangenen Jahren hat sich die Rolle der Pathologie dahingehend verändert, dass neben der klassischen Diagnostik zunehmend auch eine Einbindung in die Therapieplanung erfolgt."

During the past decade, Universitätsklinikum Göttingen, Institut für Pathologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Göttingen, Institut für Pathologie" are "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Carcinoma, Small Cell" (1 trials). Many other conditions were trialed in "Universitätsklinikum Göttingen, Institut für Pathologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Göttingen, Institut für Pathologie" are "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "PD-L1 Immunocytochemistry (ICC)" (1 trials) and "PD-L1 Immunohistochemistry (IHC)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Göttingen, Institut für Pathologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Göttingen, Institut für Pathologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitätsklinikum Göttingen, Institut für Pathologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Göttingen, Institut für Pathologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".